Latest Breaking News On - Astrazeneca pharma india limited - Page 1 : comparemela.com

Astrazeneca India Q4 net profit jumps 128% to Rs 39 cr, Rs 24 dividend declared

AstraZeneca India Q4: Revenue came in at Rs 383 crore, up 34 percent from the year-ago quarter of Rs 284 crore

AstraZeneca: India's drug regulator orders withdrawal of AstraZeneca's cancer drug due to potential adverse effects |

DCGI orders withdrawal of AstraZeneca's Olaparib tablets for gBRCA mutation and advanced ovarian cancer due to potential adverse effects. The drug was

DCGI orders withdrawal of cancer drug Olaparib for certain treatments

The communication stated that the firm presented the clinical evidence for the withdrawal of indication of Olaparib tablets.

cancer drugs | Drug Controller General of India orders withdrawal of AstraZeneca anti-cancer drug Olaparib tablets for certain treatments

CGI orders withdrawal of cancer drug Olaparib for certain treatments

Cgi orders withdrawal of cancer drug olaparib for certain treatments